We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
DuPont de Nemours
DD
$19.2B
| $5M | 0.04% |
56,087
-3,963
| -7% | -$311K |
|
327
Entegris
ENTG
$23.2B
| $5M | 0.04% |
52,013
+32,580
| +168% | +$2.85M |
|
328
Northrop Grumman
NOC
$81.2B
| $5M | 0.04% |
16,393
+4,350
| +36% | +$1.33M |
|
329
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.2B
| $4.99M | 0.04% |
78,645
+26,232
| +50% | +$1.34M |
|
330
Peloton Interactive
PTON
$2.46B
| $4.9M | 0.04% |
32,316
-2,538
| -7% | -$309K |
|
331
iShares MSCI Pacific ex Japan ETF
EPP
$2.28B
| $4.9M | 0.04% |
102,344
+5,937
| +6% | +$265K |
|
332
Rockwell Automation
ROK
$49B
| $4.85M | 0.04% |
19,349
+52
| +0.3% | +$12.7K |
|
333
Schwab US Large-Cap Growth ETF
SCHG
$62.8B
| $4.85M | 0.04% |
302,168
+4,928
| +2% | +$74.7K |
|
334
Trade Desk
TTD
$6.49B
| $4.84M | 0.04% |
60,460
+39,990
| +195% | +$3.02M |
|
335
Invesco Preferred ETF
PGX
$3.79B
| $4.84M | 0.04% |
316,960
+4,540
| +1% | +$68.1K |
|
336
Vanguard Consumer Discretionary ETF
VCR
$6.33B
| $4.83M | 0.04% |
17,543
+1,258
| +8% | +$319K |
|
337
iShares MSCI USA Min Vol Factor ETF
USMV
$24.2B
| $4.75M | 0.04% |
69,955
+1,946
| +3% | +$128K |
|
|
MRSH
338
Marsh
MRSH
$91.5B
| $4.7M | 0.04% |
40,213
+6,734
| +20% | +$765K |
|
339
Utz Brands
UTZ
$1.25B
| $4.64M | 0.04% |
210,487
+160,324
| +320% | +$3.05M |
|
340
Ameren
AEE
$30.1B
| $4.63M | 0.04% |
59,370
+37,318
| +169% | +$2.99M |
|
341
Roper Technologies
ROP
$39.8B
| $4.6M | 0.03% |
10,676
+2,222
| +26% | +$913K |
|
342
Essential Utilities
WTRG
$11.4B
| $4.6M | 0.03% |
97,238
+46,195
| +91% | +$2.05M |
|
343
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
| $4.59M | 0.03% |
23,594
-239
| -1% | -$42.2K |
|
|
344
GSK
GSK
$106B
| $4.55M | 0.03% |
98,870
-2,149,552
| -96% | -$98.7M |
|
345
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
| $4.49M | 0.03% |
237,094
+74,292
| +46% | +$1.28M |
|
346
Aptiv
APTV
$10.3B
| $4.46M | 0.03% |
34,211
+6,209
| +22% | +$690K |
|
347
General Dynamics
GD
$106B
| $4.45M | 0.03% |
29,892
+7,016
| +31% | +$1.03M |
|
348
SS&C Technologies
SSNC
$18.6B
| $4.43M | 0.03% |
60,880
+1,412
| +2% | +$94.6K |
|
349
Blackstone Mortgage Trust
BXMT
$2.38B
| $4.42M | 0.03% |
160,440
+20,805
| +15% | +$525K |
|
|
COUP
350
DELISTED
Coupa Software Incorporated
COUP
| $4.34M | 0.03% |
12,815
+5,823
| +83% | +$1.8M |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.